Pilot, Phase 2 Study Assessing Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Osimertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Jun 2016 Status changed from not yet recruiting to recruiting.
- 20 Apr 2016 Number of arms changed from 1 to 2.
- 15 Apr 2016 New trial record